Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Aug 16, 2024

SELL
$33.67 - $43.44 $505 - $651
-15 Closed
0 $0
Q3 2021

Aug 16, 2024

BUY
$30.65 - $35.68 $459 - $535
15 New
15 $490,000
Q4 2019

Aug 16, 2024

BUY
$32.75 - $41.43 $491 - $621
15 New
15 $516,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.41B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.